The Irving Institute is currently accepting applications for several pilot funding programs.

Applications are due November 1, 2017
TRx pre-proposals are due December 1, 2017

Visit here for more information.


The Irving Institute provides financial support for several core facilities across CUMC, increasing availability to investigators and optimizing utilization of these outstanding resources.

Cores supported include:

  • Biomarkers Core Laboratory
    Develops, validates and executes biochemical assays in support of pre-clinical, translational and clinical research.

  • Organic Chemistry Collaborative Center
    Supports biomedical research by providing small molecules to elucidate physiology and pathophysiology, and validate targets for drug discovery.

  • Herbert Irving Comprehensive Center Shared Resources
    Manages 15 Shared Resources that provide essential services to conduct basic and translational cancer research.

  • Research Pharmacy
    Provides inpatient and outpatient dispensing services and prepares clinical trial drug and blood/tissue sampling kits for the pharmaceutical industry, the OTC product and nutraceutical industry, and academic investigators.

For a full list of all CUMC core facilities, please visit Shared Research Facilities.